CSIMarket
 


China Pharma Holdings, Inc.  (CHPI)
Other Ticker:  
 

Cumulative China Pharma Holdings's Total Debt to Equity for Trailing Twelve Months Period

CHPI's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

CHPI Total Debt to Equity for Trailing Twelve Months Period

(Mar 31 2012)
I. Quarter
(Sep 30 2011)
III. Quarter
(Jun 30 2011)
II. Quarter


Y / Y Equity Growth - - - - -
Y / Y Total Debt Growth - - - - -
Total Debt to Equity for Trailing Twelve Months Period 0.12 0.11 0.12 - -
Total Ranking # # # # #
Seq. Equity Growth 15.35 % 9.71 % - - -
Seq. Total Debt Growth 46.89 % 1.06 % - - -


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2012
On the trailing twelve months basis Due to net new borrowings of 46.89%, Total Debt to Equity for Trailing Twelve Months Period improved to 0.12, above China Pharma Holdings's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 57 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than China Pharma Holdings. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
CHPI Charts and Quotes
Total Debt to Equity CHPI in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 58
Sector # 159
S&P 500 # 1166


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Mar 31 2012, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Bristol myers Squibb Company  0.34 
Merck and Co Inc   0.33 
Madrigal Pharmaceuticals Inc   0.31 
Johnson and Johnson  0.31 
Allergan plc  0.30 
Adicet Bio Inc   0.30 
Ani Pharmaceuticals Inc  0.28 
Celgene Corp  0.27 
Reliv International Inc  0.26 
United Therapeutics Corporation  0.26 
Tg Therapeutics Inc   0.25 
Altimmune Inc   0.24 
Arrowhead Pharmaceuticals Inc   0.20 
Seelos Therapeutics inc   0.20 
Bioxytran Inc   0.15 
Dynavax Technologies Corporation  0.15 
Emergent Biosolutions Inc   0.15 
Aveo Pharmaceuticals Inc   0.13 
Sarepta Therapeutics Inc   0.13 
China Pharma Holdings, Inc.  0.12 
Alimera Sciences Inc   0.11 
Lifecore Biomedical Inc   0.11 
Opko Health Inc   0.09 
Lexicon Pharmaceuticals Inc   0.09 
Cryoport inc   0.09 
Nature s Sunshine Products inc   0.09 
Cerevel Therapeutics Holdings Inc   0.07 
Procyon Corporation  0.07 
Lannett Company Inc  0.07 
Taro Pharmaceutical Industries Ltd  0.06 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com